Published in J Chromatogr A on March 25, 2007
Characterization of drug-protein interactions in blood using high-performance affinity chromatography. J Sep Sci (2009) 1.13
Characterization of drug interactions with serum proteins by using high-performance affinity chromatography. Curr Drug Metab (2011) 1.09
Analysis of drug interactions with high-density lipoprotein by high-performance affinity chromatography. Anal Biochem (2009) 1.00
Evaluation of silica monoliths in affinity microcolumns for high-throughput analysis of drug-protein interactions. J Sep Sci (2009) 0.98
Pharmaceutical and biomedical applications of affinity chromatography: recent trends and developments. J Pharm Biomed Anal (2012) 0.88
Affinity monolith chromatography: a review of principles and recent analytical applications. Anal Bioanal Chem (2012) 0.87
Identification and analysis of stereoselective drug interactions with low-density lipoprotein by high-performance affinity chromatography. Anal Bioanal Chem (2012) 0.85
Analysis of lidocaine interactions with serum proteins using high-performance affinity chromatography. J Chromatogr B Analyt Technol Biomed Life Sci (2010) 0.81
Analysis of drug interactions with very low density lipoprotein by high-performance affinity chromatography. Anal Bioanal Chem (2014) 0.76
Chromatographic Studies of Protein-Based Chiral Separations. Separations (2016) 0.75
In-column preparation of a brush-type chiral stationary phase using click chemistry and a silica monolith. J Sep Sci (2009) 0.75
Research in bioanalysis and separations at the University of Nebraska - Lincoln. Bioanalysis (2011) 0.75
On-column entrapment of alpha1-acid glycoprotein for studies of drug-protein binding by high-performance affinity chromatography. Anal Bioanal Chem (2016) 0.75
Analysis of stereoselective drug interactions with serum proteins by high-performance affinity chromatography: A historical perspective. J Pharm Biomed Anal (2017) 0.75
Alpha-1-acid glycoprotein. Biochim Biophys Acta (2000) 3.00
High-performance affinity chromatography: a powerful tool for studying serum protein binding. J Chromatogr B Analyt Technol Biomed Life Sci (2002) 1.84
Chiral separation mechanisms in protein-based HPLC columns. 1. Thermodynamic studies of (R)- and (S)-warfarin binding to immobilized human serum albumin. Anal Chem (1994) 1.84
Human alpha-1-glycoprotein and its interactions with drugs. Drug Metab Rev (2001) 1.65
The plasma protein binding of basic drugs. Br J Clin Pharmacol (1986) 1.49
Immobilization of alpha(1)-acid glycoprotein for chromatographic studies of drug-protein binding. Anal Biochem (2005) 1.34
Chromatographic analysis of carbamazepine binding to human serum albumin. J Chromatogr B Analyt Technol Biomed Life Sci (2005) 1.30
Evidence for binding of certain acidic drugs to alpha 1-acid glycoprotein. Biochem Pharmacol (1982) 1.29
High-performance affinity monolith chromatography: development and evaluation of human serum albumin columns. Anal Chem (2004) 1.18
Characterization of the binding and chiral separation of D- and L-tryptophan on a high-performance immobilized human serum albumin column. J Chromatogr (1993) 1.18
Affinity monolith chromatography. J Sep Sci (2006) 1.17
Chiral separation mechanisms in protein-based HPLC columns. 2. Kinetic studies of (R)- and (S)-warfarin binding to immobilized human serum albumin. Anal Chem (1996) 1.14
Studies of phenytoin binding to human serum albumin by high-performance affinity chromatography. J Chromatogr B Analyt Technol Biomed Life Sci (2004) 1.13
Affinity monoliths for ultrafast immunoextraction. Anal Chem (2005) 1.11
High-performance affinity chromatography and immobilized serum albumin as probes for drug- and hormone-protein binding. J Chromatogr B Biomed Sci Appl (2000) 1.01
Identification and quantitative studies of protein immobilization sites by stable isotope labeling and mass spectrometry. Anal Chem (2006) 1.00
Monolithic silica columns for high-efficiency chromatographic separations. J Chromatogr A (2002) 0.99
Effect of skeleton size on the performance of octadecylsilylated continuous porous silica columns in reversed-phase liquid chromatography. J Chromatogr A (1997) 0.98
Antibody immobilization to high-performance liquid chromatography supports. Characterization of maximum loading capacity for intact immunoglobulin G and Fab fragments. J Chromatogr A (2000) 0.97
Monoliths for fast bioseparation and bioconversion and their applications in biotechnology. J Sep Sci (2004) 0.97
Monolithic silica columns with various skeleton sizes and through-pore sizes for capillary liquid chromatography. J Chromatogr A (2002) 0.96
Applications of silica-based monolithic HPLC columns. J Sep Sci (2004) 0.92
Development and evaluation of N-hydroxysuccinimide-activated silica for immobilizing human serum albumin in liquid chromatography columns. J Chromatogr A (2004) 0.92
Monolithic LC columns. Anal Chem (2001) 0.90
Recent developments in the field of monolithic stationary phases for capillary electrochromatography. J Sep Sci (2005) 0.89
Comparison of monolithic silica and polymethacrylate capillary columns for LC. J Sep Sci (2004) 0.88
Monoliths as stationary phases for separation of proteins and polynucleotides and enzymatic conversion. J Chromatogr B Biomed Sci Appl (2001) 0.85
Monolithic silica columns for high-efficiency separations by high-performance liquid chromatography. J Chromatogr A (2002) 0.85
Comparison of the efficiency of microparticulate and monolithic capillary columns. J Sep Sci (2004) 0.85
pH-dependence of warfarin binding to alpha 1-acid glycoprotein (orosomucoid). Biochem J (1993) 0.84
Evaluation of a hydrazide-linked alpha1-acid glycoprotein chiral stationary phase: separation of R- and S-propranolol. J Sep Sci (2006) 0.84
Development of a bioreactor based on trypsin immobilized on monolithic support for the on-line digestion and identification of proteins. J Chromatogr A (2004) 0.84
Crystallization of alpha 1-acid glycoprotein. Biochem Biophys Res Commun (1984) 0.81
Optimization of the separation of enantiomers of basic drugs. Retention mechanisms and dynamic modification of the chiral bonding properties on an alpha 1-acid glycoprotein column. J Chromatogr A (1995) 0.80
Affinity processes realized on high-flow-through methacrylate-based macroporous monoliths. J Chromatogr A (2005) 0.79
[Drug binding analysis of human alpha 1-acid glycoprotein using capillary electrophoresis]. Yakugaku Zasshi (2003) 0.79
Preparation and evaluation of a molecularly imprinted polymer derivatized silica monolithic column for capillary electrochromatography and capillary liquid chromatography. Anal Chem (2007) 0.78
Evaluation of a monolithic epoxy silica support for penicillin G acylase immobilization. J Chromatogr A (2004) 0.78
Development of a chromatographic bioreactor based on immobilized beta-glucuronidase on monolithic support for the determination of dextromethorphan and dextrorphan in human urine. J Pharm Biomed Anal (2004) 0.78
Monolithic silica-based capillary column with strong chiral cation-exchange type surface modification for enantioselective non-aqueous capillary electrochromatography. J Chromatogr A (2006) 0.77
Separation of the enantiomers of beta-receptor blocking agents and other cationic drugs using a CHIRAL-AGP column. Binding properties and characterization of immobilized alpha 1-acid glycoprotein. J Chromatogr (1990) 0.77
Quantitative analysis of allosteric drug-protein binding by biointeraction chromatography. Nat Biotechnol (2004) 1.74
Immobilization of alpha(1)-acid glycoprotein for chromatographic studies of drug-protein binding. Anal Biochem (2005) 1.34
Chromatographic analysis of carbamazepine binding to human serum albumin. J Chromatogr B Analyt Technol Biomed Life Sci (2005) 1.30
Review: Glycation of human serum albumin. Clin Chim Acta (2013) 1.19
Analysis of free hormone fractions by an ultrafast immunoextraction/displacement immunoassay: studies using free thyroxine as a model system. Anal Chem (2005) 1.19
High-performance affinity monolith chromatography: development and evaluation of human serum albumin columns. Anal Chem (2004) 1.18
Characterization of glycation adducts on human serum albumin by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Clin Chim Acta (2007) 1.18
Affinity monolith chromatography. J Sep Sci (2006) 1.17
Analysis of free drug fractions using near-infrared fluorescent labels and an ultrafast immunoextraction/displacement assay. Anal Chem (2006) 1.15
Binding of tolbutamide to glycated human serum albumin. J Pharm Biomed Anal (2010) 1.15
Comparison of modification sites formed on human serum albumin at various stages of glycation. Clin Chim Acta (2010) 1.14
Studies of phenytoin binding to human serum albumin by high-performance affinity chromatography. J Chromatogr B Analyt Technol Biomed Life Sci (2004) 1.13
Estimating protein-ligand binding affinity using high-throughput screening by NMR. J Comb Chem (2008) 1.12
Chromatographic analysis of acetohexamide binding to glycated human serum albumin. J Chromatogr B Analyt Technol Biomed Life Sci (2010) 1.11
Characterization of the binding of sulfonylurea drugs to HSA by high-performance affinity chromatography. J Chromatogr B Analyt Technol Biomed Life Sci (2010) 1.11
Affinity monoliths for ultrafast immunoextraction. Anal Chem (2005) 1.11
Evaluation of indole-based probes for high-throughput screening of drug binding to human serum albumin: Analysis by high-performance affinity chromatography. J Sep Sci (2009) 1.10
The effects of glycation on the binding of human serum albumin to warfarin and L-tryptophan. J Pharm Biomed Anal (2010) 1.09
Evaluation of alternatives to warfarin as probes for Sudlow site I of human serum albumin: characterization by high-performance affinity chromatography. J Chromatogr A (2008) 1.08
Analysis of drug-protein binding by ultrafast affinity chromatography using immobilized human serum albumin. J Chromatogr A (2010) 1.05
Quantitative analysis of glycation patterns in human serum albumin using 16O/18O-labeling and MALDI-TOF MS. Clin Chim Acta (2011) 1.05
Development of sulfhydryl-reactive silica for protein immobilization in high-performance affinity chromatography. Anal Chem (2007) 1.03
Obtaining high sequence coverage in matrix-assisted laser desorption time-of-flight mass spectrometry for studies of protein modification: analysis of human serum albumin as a model. Anal Biochem (2005) 1.03
Chromatographic analysis of carbamazepine binding to human serum albumin. II. Comparison of the Schiff base and N-hydroxysuccinimide immobilization methods. J Chromatogr B Analyt Technol Biomed Life Sci (2006) 1.02
Kinetic studies of biological interactions by affinity chromatography. J Sep Sci (2009) 1.02
Immobilization of alpha1-acid glycoprotein for chromatographic studies of drug-protein binding II. correction for errors in association constant measurements. Anal Biochem (2008) 1.01
Analysis of drug interactions with high-density lipoprotein by high-performance affinity chromatography. Anal Biochem (2009) 1.00
Identification and quantitative studies of protein immobilization sites by stable isotope labeling and mass spectrometry. Anal Chem (2006) 1.00
High-performance affinity chromatography and the analysis of drug interactions with modified proteins: binding of gliclazide with glycated human serum albumin. Anal Bioanal Chem (2011) 0.99
Stability of warfarin solutions for drug-protein binding measurements: spectroscopic and chromatographic studies. J Pharm Biomed Anal (2006) 0.99
Studies by biointeraction chromatography of binding by phenytoin metabolites to human serum albumin. J Chromatogr B Analyt Technol Biomed Life Sci (2006) 0.99
Measurement of drug-protein dissociation rates by high-performance affinity chromatography and peak profiling. Anal Chem (2009) 0.99
Evaluation of silica monoliths in affinity microcolumns for high-throughput analysis of drug-protein interactions. J Sep Sci (2009) 0.98
Quantitative analysis of glycation sites on human serum albumin using (16)O/(18)O-labeling and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Clin Chim Acta (2010) 0.98
Development of a flow-based ultrafast immunoextraction and reverse displacement immunoassay: analysis of free drug fractions. Anal Chem (2011) 0.97
Immunoaffinity chromatography: an introduction to applications and recent developments. Bioanalysis (2010) 0.96
Quantitative studies of allosteric effects by biointeraction chromatography: analysis of protein binding for low-solubility drugs. Anal Chem (2006) 0.96
Use of peak decay analysis and affinity microcolumns containing silica monoliths for rapid determination of drug-protein dissociation rates. J Chromatogr A (2010) 0.96
Development of an affinity silica monolith containing human serum albumin for chiral separations. J Pharm Biomed Anal (2007) 0.94
Applications of silica supports in affinity chromatography. J Sep Sci (2006) 0.94
Kinetic studies of drug-protein interactions by using peak profiling and high-performance affinity chromatography: examination of multi-site interactions of drugs with human serum albumin columns. J Chromatogr A (2010) 0.93
Entrapment of proteins in glycogen-capped and hydrazide-activated supports. Anal Biochem (2010) 0.93
Analysis of free fractions for chiral drugs using ultrafast extraction and multi-dimensional high-performance affinity chromatography. Analyst (2013) 0.92
Chromatographic studies of changes in binding of sulfonylurea drugs to human serum albumin due to glycation and fatty acids. J Chromatogr B Analyt Technol Biomed Life Sci (2010) 0.92
Development and evaluation of N-hydroxysuccinimide-activated silica for immobilizing human serum albumin in liquid chromatography columns. J Chromatogr A (2004) 0.92
Studies of verapamil binding to human serum albumin by high-performance affinity chromatography. J Chromatogr B Analyt Technol Biomed Life Sci (2008) 0.91
System suitability in bioanalytical LC/MS/MS. J Pharm Biomed Anal (2007) 0.90
Analysis of drug interactions with modified proteins by high-performance affinity chromatography: binding of glibenclamide to normal and glycated human serum albumin. J Chromatogr A (2012) 0.89
Determination of rate constants and equilibrium constants for solution-phase drug-protein interactions by ultrafast affinity extraction. Anal Chem (2014) 0.89
Optimization of human serum albumin monoliths for chiral separations and high-performance affinity chromatography. J Chromatogr A (2012) 0.89
Noncompetitive peak decay analysis of drug-protein dissociation by high-performance affinity chromatography. J Sep Sci (2009) 0.89
Evaluation of affinity microcolumns containing human serum albumin for rapid analysis of drug-protein binding. J Chromatogr B Analyt Technol Biomed Life Sci (2010) 0.88
Characterization of interaction kinetics between chiral solutes and human serum albumin by using high-performance affinity chromatography and peak profiling. J Chromatogr A (2011) 0.87
Factors affecting the stability of drugs and drug metabolites in biological matrices. Bioanalysis (2009) 0.87
Chromatographic analysis of allosteric effects between ibuprofen and benzodiazepines on human serum albumin. Chirality (2006) 0.87
Development of affinity microcolumns for drug-protein binding studies in personalized medicine: interactions of sulfonylurea drugs with in vivo glycated human serum albumin. Anal Chem (2013) 0.87
Affinity monolith chromatography: a review of principles and recent analytical applications. Anal Bioanal Chem (2012) 0.87
Use of entrapment and high-performance affinity chromatography to compare the binding of drugs and site-specific probes with normal and glycated human serum albumin. Anal Bioanal Chem (2013) 0.87
Biointeraction analysis by high-performance affinity chromatography: Kinetic studies of immobilized antibodies. J Chromatogr B Analyt Technol Biomed Life Sci (2009) 0.86
Capillary electrophoresis-based immunoassays: principles and quantitative applications. Electrophoresis (2008) 0.86
Identification and analysis of stereoselective drug interactions with low-density lipoprotein by high-performance affinity chromatography. Anal Bioanal Chem (2012) 0.85
Identification of drug-binding sites on human serum albumin using affinity capillary electrophoresis and chemically modified proteins as buffer additives. Electrophoresis (2002) 0.85
Current trends in the detection of peroxide-based explosives. Anal Bioanal Chem (2009) 0.85
Biointeraction analysis of carbamazepine binding to alpha1-acid glycoprotein by high-performance affinity chromatography. J Sep Sci (2010) 0.85
High-throughput analysis of drug dissociation from serum proteins using affinity silica monoliths. J Sep Sci (2011) 0.84
Evaluation of a hydrazide-linked alpha1-acid glycoprotein chiral stationary phase: separation of R- and S-propranolol. J Sep Sci (2006) 0.84
Studies of imipramine binding to human serum albumin by high-performance affinity chromatography. J Chromatogr B Analyt Technol Biomed Life Sci (2009) 0.84
Chromatographic competitive binding immunoassays: a comparison of the sequential and simultaneous injection methods. Biomed Chromatogr (2003) 0.84
Characterization of drug interactions with soluble beta-cyclodextrin by high-performance affinity chromatography. J Chromatogr A (2004) 0.83
Detection of heterogeneous drug-protein binding by frontal analysis and high-performance affinity chromatography. J Chromatogr A (2011) 0.81
Analysis of lidocaine interactions with serum proteins using high-performance affinity chromatography. J Chromatogr B Analyt Technol Biomed Life Sci (2010) 0.81
Development of a portable immunoextraction-reversed-phase liquid chromatography system for field studies of herbicide residues. Anal Chem (2004) 0.81
Environmental analysis by on-line immunoextraction and reversed-phase liquid chromatography: optimization of the immunoextraction/RPLC interface. J Agric Food Chem (2007) 0.80
Biointeraction analysis of immobilized antibodies and related agents by high-performance immunoaffinity chromatography. Methods (2011) 0.80
Preparation of high-capacity supports containing protein G immobilized to porous silica. Anal Biochem (2010) 0.79
Clinical applications of capillary electrophoresis based immunoassays. Electrophoresis (2013) 0.79
Analysis of drug-protein interactions by high-performance affinity chromatography: interactions of sulfonylurea drugs with normal and glycated human serum albumin. Methods Mol Biol (2015) 0.77
Determination of free catecholamines in urine by tandem affinity/ion-pair chromatography and flow injection analysis. Clin Chim Acta (2008) 0.77
Biointeraction affinity chromatography: general principles and recent developments. Adv Chromatogr (2010) 0.77
Analysis of drug interactions with very low density lipoprotein by high-performance affinity chromatography. Anal Bioanal Chem (2014) 0.76
Studies of drug interactions with glycated human serum albumin by high-performance affinity chromatography. Rev Anal Chem (2014) 0.76
Development of immunoaffinity restricted access media for rapid extractions of low-mass analytes. Anal Chem (2008) 0.75
Analysis of glipizide binding to normal and glycated human serum albumin by high-performance affinity chromatography. Anal Bioanal Chem (2015) 0.75
Screening major binding sites on human serum albumin by affinity capillary electrophoresis. Methods Mol Biol (2004) 0.75
Density measurements of potassium phosphate buffer from 4 to 45 degrees C. Talanta (2005) 0.75
18-crown-6 as a class I organic modifier in MEKC. Electrophoresis (2009) 0.75